Clinical Trial Update: Study of INCB123667 in Subjects With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study of INCB123667 in advanced solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• INCB123667 (INCB123667)

Snippet

Sponsor: Incyte Corporation | Conditions: Solid Tumors | Phase 1 | Status: RECRUITING